AAAAAA
Results: 101-125/696
Citation: SEREVENT - LONG-TERM MAINTENANCE TREATMENT OF CCPD-INDUCED BRONCHOSPASM, Formulary, 33(4), 1998, pp. 292-292
Citation: ALLEGRA-D - COMBINATION ANTIHISTAMINE AND NASAL DECONGESTANT FOR ALLERGIC RHINITIS, Formulary, 33(4), 1998, pp. 292-292
NORITATE CREAM, 1-PERCENT - CREAM FORMULATION OF ANTIINFLAMMATORY FORLESIONS AND ERYTHEMA OF ROSACEA
Citation: NORITATE CREAM, 1-PERCENT - CREAM FORMULATION OF ANTIINFLAMMATORY FORLESIONS AND ERYTHEMA OF ROSACEA, Formulary, 33(4), 1998, pp. 292-292
Citation: TOBI - INHALED FORMULATION FOR USE IN CYSTIC-FIBROSIS PATIENTS WITH PSEUDOMONAS-AERUGINOSA, Formulary, 33(4), 1998, pp. 297-297
Citation: OPTISON - CARDIAC ULTRASOUND IMAGING AGENT, Formulary, 33(4), 1998, pp. 297-297
Citation: SEREVENT DISKUS - DRY POWDER FORM OF BRONCHODILATOR, Formulary, 33(4), 1998, pp. 297-297
Citation: ESTERIFIED ESTROGENS PREVENT BONE LOSS AT DOSES LOWER THAN THOSE USEDFOR OTHER ESTROGENS, Formulary, 33(4), 1998, pp. 298
Citation: UNITED HEALTH-CARE TAKES ITS TIERED RX COPAYMENT PROGRAM NATIONWIDE, Formulary, 33(4), 1998, pp. 298-298
Citation: SURVEY PROBES PHYSICIAN BELIEFS ON GENERIC SUBSTITUTION, Formulary, 33(4), 1998, pp. 301-302
Citation: INTENSIVE IV INSULIN PROTOCOL CUTS INFECTION RISK IN DIABETIC HEART-SURGERY PATIENTS, Formulary, 33(4), 1998, pp. 302-302
Authors:
ASHWORTH LE
Citation: Le. Ashworth, FOCUS ON RALOXIFENE - A SELECTIVE ESTROGEN-RECEPTOR MODULATOR FOR PREVENTION OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN, Formulary, 33(4), 1998, pp. 305
Authors:
CHANDRAMOULI JB
STOKES JB
Citation: Jb. Chandramouli et Jb. Stokes, USE OF ACE-INHIBITORS IN DIABETIC AND NONDIABETIC PATIENTS WITH RENAL-DISEASE, Formulary, 33(4), 1998, pp. 318
Authors:
GALANT SP
Citation: Sp. Galant, PHARMACOTHERAPEUTIC OPTIONS FOR THE MANAGEMENT OF ASTHMA, Formulary, 33(4), 1998, pp. 343
Authors:
BASSKIN L
Citation: L. Basskin, EVALUATING THE COST-EFFECTIVENESS OF INTERVENTIONS TO REDUCE NONCOMPLIANCE, Formulary, 33(4), 1998, pp. 359
Authors:
AKINWANDE K
HALESMCDONALD R
FREDERICK E
WARREN R
Citation: K. Akinwande et al., AMPICILLIN SULBACTAM - EFFICACY AND COST COMPARISON OF 1.5 AND 3-GRAMDOSES/, Formulary, 33(4), 1998, pp. 369
Citation: DOCUMENTING MEDICATION USE BY DIAGNOSIS RELATED GROUP, Formulary, 33(4), 1998, pp. 380-381
Citation: INSTITUTIONAL GUIDELINES FOR APPROPRIATE VANCOMYCIN USE, Formulary, 33(4), 1998, pp. 380-380
Citation: FILGRASTIM PROTOCOL RESULTS IN COST SAVINGS, NO LOSS OF CLINICAL EFFICACY, Formulary, 33(4), 1998, pp. 381-381
Authors:
WECHSLER J
Citation: J. Wechsler, 1999 BUDGET BOOSTS MEDICAL-RESEARCH FUNDING BUT MAY SHORTCHANGE FDA OPERATIONS, Formulary, 33(4), 1998, pp. 385-386
Citation: EVISTA - SELECTIVE ESTROGEN-RECEPTOR MODULATOR FOR THE PREVENTION OF OSTEOPOROSIS, Formulary, 33(3), 1998, pp. 175-176
Citation: ANTIZOL - ANTIDOTE FOR ETHYLENE-GLYCOL POISONING, Formulary, 33(3), 1998, pp. 175-175
Citation: OMNICEF - ORAL CEPHALOSPORIN WITH ONCE-DAILY DOSING FOR SELECTED INFECTIONS, Formulary, 33(3), 1998, pp. 176-176
Citation: REGRANEX - PLATELET GROWTH-FACTOR FOR TREATING DIABETIC ULCERS OF THELEG AND FOOT, Formulary, 33(3), 1998, pp. 176-177
Citation: TESLASCAN - CONTRAST AGENT ENHANCES MRIS USED TO EVALUATE LIVER-LESIONS, Formulary, 33(3), 1998, pp. 177-177
Citation: SCLEROSOL - TALC FOR PREVENTING MALIGNANT PLEURAL EFFUSIONS DURING THORACIC PROCEDURES, Formulary, 33(3), 1998, pp. 177-177